A meta-analysis of perioperative beta blockade: what is the actual risk reduction?

[1]  K. Leslie,et al.  A large trial is vital to prove perioperative beta-blockade effectiveness and safety before widespread use. , 2004, Anesthesiology.

[2]  J. Sear,et al.  Effect of chronic β‐blockade on peri‐operative outcome in patients undergoing non‐cardiac surgery: an analysis of observational and case control studies* , 2004 .

[3]  Justin B Dimick,et al.  Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. , 2004, Surgery.

[4]  P. Lindenauer,et al.  The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. , 2004, Archives of internal medicine.

[5]  G. Jensen,et al.  The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. , 2004, American heart journal.

[6]  J. Mattana,et al.  Lack of physician concordance with guidelines on the perioperative use of beta-blockers. , 2004, Archives of internal medicine.

[7]  Belinda Young,et al.  Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. , 2003, The American journal of medicine.

[8]  E. Etchells,et al.  Successful implementation of perioperative betablockade utilizing a multidisciplinary approach , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[9]  L. Goldman,et al.  beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.

[10]  E. Antman,et al.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat , 2002, Circulation.

[11]  Michael Schmidt,et al.  Forecasting the impact of a clinical practice guideline for perioperative beta-blockers to reduce cardiovascular morbidity and mortality. , 2002, Archives of internal medicine.

[12]  Jeroen J. Bax,et al.  Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. , 2001, JAMA.

[13]  Douglas G Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[14]  Jeroen J. Bax,et al.  Predictors of Cardiac Events After Major Vascular Surgery Role of Clinical Characteristics, Dobutamine Echocardiography, and b-Blocker Therapy , 2001 .

[15]  P. Kligfield,et al.  Postoperative Prophylactic Administration of &bgr;-Adrenergic Blockers in Patients at Risk for Myocardial Ischemia , 2000, Anesthesia and analgesia.

[16]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[17]  D. Reich,et al.  Beneficial Effects from β-Adrenergic Blockade in Elderly Patients Undergoing Noncardiac Surgery , 1999 .

[18]  A Laupacis,et al.  Assessing the quality of randomized trials: reliability of the Jadad scale. , 1999, Controlled clinical trials.

[19]  Farris K. Timimi,et al.  The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. , 1999, Anesthesia and analgesia.

[20]  M. Packer,et al.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. , 1998, Circulation.

[21]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[22]  George Davey Smith,et al.  meta-analysis bias in location and selection of studies , 1998 .

[23]  A. Wallace,et al.  Prophylactic Atenolol Reduces Postoperative Myocardial Ischemia , 1998, Anesthesiology.

[24]  George Davey Smith,et al.  Meta-analysis: Principles and procedures , 1997, BMJ.

[25]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[26]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[27]  L. Goldman,et al.  Preoperative assessment of patients with known or suspected coronary disease. , 1995, The New England journal of medicine.

[28]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[29]  E. Cook,et al.  Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. , 1992, JAMA.

[30]  J. Sear,et al.  Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. , 1988, British journal of anaesthesia.

[31]  J. Sear,et al.  Myocardial Ischemia in Untreated Hypertensive Patients: Effect of a Single Small Oral Dose of a Beta‐Adrenergic Blocking Agent , 1988, Anesthesiology.